Latest News

FDA Approves Fluorescence Imaging System for Detecting Residual Breast Cancer
FDA Approves Fluorescence Imaging System for Detecting Residual Breast Cancer

April 18th 2024

The combination of the optical imaging agent Lumisight and the fluorescence imaging device Lumicell Direct Visualization System, collectively known as LumiSystem, reportedly offers 84 percent accuracy with real-time detection of residual breast cancer after lumpectomy procedures.

PET/CT or mpMRI: Which is Better for Detecting Biochemical Recurrence of PCa?
PET/CT or mpMRI: Which is Better for Detecting Biochemical Recurrence of Prostate Cancer?

April 17th 2024

Study of Ofatumumab for Multiple Sclerosis Shows ‘Profoundly Suppressed MRI Lesion Activity’
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'

April 17th 2024

Can GPT-4 Improve Accuracy in Radiology Reports?
Can GPT-4 Improve Accuracy in Radiology Reports?

April 16th 2024

Emerging PET Agent Gets FDA Fast Track Designation for Glioma Imaging
Emerging PET Agent Gets FDA Fast Track Designation for Glioma Imaging

April 16th 2024

Video Interviews

Latest Conference Coverage

View All
Study of Ofatumumab for Multiple Sclerosis Shows ‘Profoundly Suppressed MRI Lesion Activity’
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'

April 17th 2024

Could a Deep Learning Model for Mammography Improve Prediction of DCIS and Invasive Breast Cancer?
Could a Deep Learning Model for Mammography Improve Prediction of DCIS and Invasive Breast Cancer?

April 15th 2024

Improving the Quality of Breast MRI Acquisition and Processing
Improving the Quality of Breast MRI Acquisition and Processing

April 12th 2024

Interventional Radiology Study Shows Low Breast Cancer Recurrence 16 Months After Cryoablation
Interventional Radiology Study Shows Low Breast Cancer Recurrence 16 Months After Cryoablation

March 29th 2024

All News

© 2024 MJH Life Sciences

All rights reserved.